Prevalence of dysplasia in juvenile-onset recurrent respiratory papillomatosis

Archives of Otolaryngology - Head and Neck Surgery

Volumn 136, Issue 1, 2010, Pages 7-11

  Sajan, Javad A ^a   Kerschner, Joseph E ^a   Merati, Albert L ^c   Osipov, Vladimir ^b   Szabo, Sara ^b   Blumin, Joel H ^a  

^a Department of Otolaryngology and Communication Sciences ^*  (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIDOFOVIR; MUMPS VACCINE;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DYSPLASIA; GROUPS BY AGE; HUMAN; INFANT; JUVENILE; MEDICAL RECORD; MEDICAL RECORD REVIEW; MUMPS; OUTCOME ASSESSMENT; PAPILLOMATOSIS; PATIENT IDENTIFICATION; PEDIATRIC HOSPITAL; PHOTODYNAMIC THERAPY; POPULATION; PRESCHOOL CHILD; PREVALENCE; RECURRENT DISEASE; RESPIRATORY PAPILLOMATOSIS; RESPIRATORY TRACT DISEASE; RETROSPECTIVE STUDY; SCHOOL CHILD; SMOKING;

ADOLESCENT; ANTINEOPLASTIC AGENTS; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; CYTOSINE; FEMALE; HUMANS; INFANT; LARYNGEAL NEOPLASMS; MALE; NEOPLASM RECURRENCE, LOCAL; PAPILLOMA; PHOSPHONIC ACIDS; PREVALENCE; RETROSPECTIVE STUDIES; WISCONSIN;

EID: 74949110631     PISSN: 08864470     EISSN: 08864470     Source Type: Journal    
DOI: 10.1001/archoto.2009.179     Document Type: Article

References (15)

1. Derkay CS. Task force on recurrent respiratory papillomas: a preliminary report. Arch Otolaryngol Head Neck Surg. 1995;121(12):1386-1391.
2. Reeves WC, Ruparelia SS, Swanson KI, Derkay CS, Marcus A, Unger ER. National registry for juvenile-onset recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg. 2003;129(9):976-982.
3. De Clercq E. Therapeutic potential of cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus) infections. Verh K Acad Geneeskd Belg. 1996;58(1):19-47.
4. Stamataki S, Nikolopoulos TP, Korres S, Felekis D, Tzangaroulakis A, Ferekidis E. Juvenile recurrent respiratory papillomatosis: still a mystery disease with difficult management. Head Neck. 2007;29(2):155-162.
5. Wemer RD, Lee JH, Hoffman HT, Robinson RA, Smith RJ. Case of progressive dysplasia concomitant with intralesional cidofovir administration for recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol. 2005;114(11):836-839.
6. Snoeck R, Wellens W, Desloovere C, et al. Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2- phosphonylmethoxypropyl)cytosine]. J Med Virol. 1998;54(3):219-225.
7. Lee LA, Cheng AJ, Fang TJ, et al. High incidence of malignant transformation of laryngeal papilloma in Taiwan. Laryngoscope. 2008;118(1):50-55.
8. Lindsay F, Bloom D, Pransky S, Stabley R, Shick P. Histologic review of cidofovirtreated recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol. 2008; 117(2):113-117.
9. Ho GYF, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med. 1998;338 (7):423-428.
10. Derkay CS, Wiatrak B. Recurrent respiratory papillomatosis: a review. Laryngoscope. 2008;118(7):1236-1247.
11. Blumin JH, Handler EB, Simpson CB, Osipov V, Merati AL. Dysplasia in adults with recurrent respiratory papillomatosis: incidence and risk factors. Ann Otol Rhinol Laryngol. 2009;118(7):481-485.
12. Johnson JT, Barnes EL, Justice W. Adult onset laryngeal papillomatosis. Otolaryngol Head Neck Surg. 1981;89(5):867-873.
13. Hartley C, Hamilton J, Birzgalis AR, Farrington WT. Recurrent respiratory papillomatosis: the Manchester experience, 1974-1992. J Laryngol Otol. 1994; 108(3):226-229.
14. Freed GL, Derkay CS. Prevention of recurrent respiratory papillomatosis: role of HPV vaccination. Int J Pediatr Otorhinolaryngol. 2006;70(10):1799-1803.
15. Pransky SM, Albright JT, Magit AE. Long-term follow-up of pediatric recurrent respiratory papillomatosis managed with intralesional cidofovir. Laryngoscope. 2003;113(9):1583-1587.